Arcutis Biotherapeutics, Inc. ARQT Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s change in AP?
- Arcutis Biotherapeutics, Inc. (ARQT) reported change in AP of $5.61M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s change in AP changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s change in AP increased by 1716.5% year-over-year, from $309K to $5.61M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.